These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25262866)

  • 21. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator.
    Sieira J; Brugada P
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906652
    [No Abstract]   [Full Text] [Related]  

  • 22. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late potential at the high ventricular septal level in a patient with Brugada: possible mechanisms and clinical implications.
    Baez-Escudero JL; Shah DP; Weisberg IL; Beshai JF; Burke MC
    J Electrocardiol; 2010; 43(5):459-62. PubMed ID: 20728020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
    Dukkipati SR; d'Avila A; Soejima K; Bala R; Inada K; Singh S; Stevenson WG; Marchlinski FE; Reddy VY
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):185-94. PubMed ID: 21270104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epicardial substrate ablation for Brugada syndrome.
    Nademanee K; Hocini M; Haïssaguerre M
    Heart Rhythm; 2017 Mar; 14(3):457-461. PubMed ID: 27979714
    [No Abstract]   [Full Text] [Related]  

  • 28. Current review of Brugada syndrome: from epidemiology to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():12-6. PubMed ID: 20089482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and catheter ablation of ventricular tachycardia.
    Reddy VY
    Tex Heart Inst J; 2005; 32(2):202-3. PubMed ID: 16107114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter defibrillator lead placement in the right ventricular outflow tract in a patient with Brugada syndrome and persistent left superior vena cava.
    Korantzopoulos P; Kolios M; Nikas D; Goudevenos JA
    Int J Cardiol; 2015 Feb; 181():166-8. PubMed ID: 25497546
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Defibrillator implantation associated with ventricular arrhythmia ablation: an emerging hybrid approach].
    Lavalle C; Pandozi C; Santini M
    G Ital Cardiol (Rome); 2012 Feb; 13(2):110-7. PubMed ID: 22322551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? Alternatives to Implantable Cardiac Defibrillator Therapy for Brugada Syndrome.
    Belhassen B
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906651
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent advances in the treatment of Brugada syndrome.
    Argenziano M; Antzelevitch C
    Expert Rev Cardiovasc Ther; 2018 Jun; 16(6):387-404. PubMed ID: 29757020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of stored implanted cardiac defibrillator electrograms in catheter ablation of ventricular fibrillation.
    Lowery CM; Tzou WS; Aleong RG; Nguyen DT; Varosy PD; Katz DF; Heath RR; Schuller JL; Lewkowiez L; Sauer WH
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):76-85. PubMed ID: 23078144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.
    Belhassen B; Viskin S
    Can J Cardiol; 2014 Nov; 30(11):1460.e3-5. PubMed ID: 25240706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.